Natalya V. Serbina, Ph.D. - Publications

Affiliations: 
2000 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Immunology

24/33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Serbina NV, Shi C, Pamer EG. Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Advances in Immunology. 113: 119-34. PMID 22244581 DOI: 10.1016/B978-0-12-394590-7.00003-8  0.96
2011 Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, Lipuma L, Leiner I, Li MO, Frenette PS, Pamer EG. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity. 34: 590-601. PMID 21458307 DOI: 10.1016/j.immuni.2011.02.016  0.96
2009 Serbina NV, Cherny M, Shi C, Bleau SA, Collins NH, Young JW, Pamer EG. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. Journal of Immunology (Baltimore, Md. : 1950). 183: 2678-87. PMID 19635902 DOI: 10.4049/jimmunol.0803398  0.96
2009 Serbina NV, Hohl TM, Cherny M, Pamer EG. Selective expansion of the monocytic lineage directed by bacterial infection. Journal of Immunology (Baltimore, Md. : 1950). 183: 1900-10. PMID 19596996 DOI: 10.4049/jimmunol.0900612  0.96
2008 Serbina NV, Pamer EG. Coordinating innate immune cells to optimize microbial killing. Immunity. 29: 672-4. PMID 19006691 DOI: 10.1016/j.immuni.2008.10.003  0.96
2008 Jia T, Serbina NV, Brandl K, Zhong MX, Leiner IM, Charo IF, Pamer EG. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. Journal of Immunology (Baltimore, Md. : 1950). 180: 6846-53. PMID 18453605  0.96
2008 Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annual Review of Immunology. 26: 421-52. PMID 18303997 DOI: 10.1146/annurev.immunol.26.021607.090326  0.96
2007 Park-Min KH, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB. FcγRIII-Dependent Inhibition of Interferon-γ Responses Mediates Suppressive Effects of Intravenous Immune Globulin Immunity. 26: 67-78. PMID 17239631 DOI: 10.1016/j.immuni.2006.11.010  0.96
2006 Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nature Immunology. 7: 311-7. PMID 16462739 DOI: 10.1038/ni1309  0.96
2004 Zhong MX, Kuziel WA, Pamer EG, Serbina NV. Chemokine receptor 5 is dispensable for innate and adaptive immune responses to Listeria monocytogenes infection. Infection and Immunity. 72: 1057-64. PMID 14742553 DOI: 10.1128/IAI.72.2.1057-1064.2004  0.96
2003 Serbina NV, Kuziel W, Flavell R, Akira S, Rollins B, Pamer EG. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity. 19: 891-901. PMID 14670305 DOI: 10.1016/S1074-7613(03)00330-3  0.96
2003 Serbina NV, Pamer EG. Immunology. Giving credit where credit is due. Science (New York, N.Y.). 301: 1856-7. PMID 14512609 DOI: 10.1126/science.1090613  0.96
2003 Serbina N, Pamer EG. Quantitative studies of CD8+ T-cell responses during microbial infection. Current Opinion in Immunology. 15: 436-42. PMID 12900276 DOI: 10.1016/S0952-7915(03)00071-2  0.96
2003 Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19: 59-70. PMID 12871639 DOI: 10.1016/S1074-7613(03)00171-7  0.96
2002 Brennan PJ, Terwilliger T, Barry CE, Manca C, Su H, Reed M, Rutter K, Domenech P, Kaplan G, Li YJ, Wagner D, Bermudez LE, Bodnar K, Flynn J, Campos-Neto A, ... ... Serbina N, et al. The US-Japan Cooperative Medical Science Program Tuberculosis and Leprosy Panel's 36th annual research conference, New Orleans, Louisiana, USA, 15-17 July 2001 Tuberculosis. 82: 113-135. PMID 12408170 DOI: 10.1054/tube.2002.0329  0.96
2001 Serbina NV, Lazarevic V, Flynn JL. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. Journal of Immunology (Baltimore, Md. : 1950). 167: 6991-7000. PMID 11739519  0.96
2001 Lauvau G, Vijh S, Kong P, Horng T, Kerksiek K, Serbina N, Tuma RA, Pamer EG. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine Science. 294: 1735-1739. PMID 11721060 DOI: 10.1126/science.1064571  0.96
2001 Serbina NV, Flynn JL. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infection and Immunity. 69: 4320-8. PMID 11401969 DOI: 10.1128/IAI.69.7.4320-4328.2001  0.96
2001 Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, Flynn JL, Wang CR. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. The Journal of Experimental Medicine. 193: 1213-20. PMID 11369792 DOI: 10.1084/jem.193.10.1213  0.96
2001 Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR. Vaccination with the T cell antigen Mtb 8.4 Protects against challenge with Mycobacterium tuberculosis Journal of Immunology. 166: 6227-6235. PMID 11342645 DOI: 10.4049/jimmunol.166.10.6227  0.96
2001 Bodnar KA, Serbina NV, Flynn JL. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infection and Immunity. 69: 800-9. PMID 11159971 DOI: 10.1128/IAI.69.2.800-809.2001  0.96
2000 Serbina NV, Liu CC, Scanga CA, Flynn JL. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. Journal of Immunology (Baltimore, Md. : 1950). 165: 353-63. PMID 10861072  0.96
1999 Serbina NV, Flynn JL. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infection and Immunity. 67: 3980-8. PMID 10417164  0.96
1999 Serbina NV, Flynn JL. Early emergence of CD8+ T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice International Journal of Leprosy and Other Mycobacterial Diseases. 67: 509-510.  0.96
Low-probability matches
2000 Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, Flynn JL, Barnes PF, Southwood S, Celis E, Bloom BR, Modlin RL, Sette A. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 97: 12210-5. PMID 11035787 DOI: 10.1073/pnas.210391497  0.04
1996 Huang L, Farhood H, Serbina N, Teepe AG, Barsoum J. Endosomolytic activity of cationic liposomes enhances the delivery of human immunodeficiency virus-1 trans-activator protein (TAT) to mammalian cells. Biochemical and Biophysical Research Communications. 217: 761-8. PMID 8554596 DOI: 10.1006/bbrc.1995.2838  0.04
2019 Thakurta A, Ortiz M, Blecua P, Towfic F, Corre J, Serbina NV, Flynt E, Yu Z, Yang Z, Palumbo A, Dimopoulos MA, Guttierez N, Goldschmidt H, Sonneveld P, Avet-Loiseau H. High sub-clonal fraction of 17p deletion is associated with poor prognosis in Multiple Myeloma. Blood. PMID 30692124 DOI: 10.1182/blood-2018-10-880831  0.01
2018 Katz M, Bjorklund CC, Thakurta A, Serbina N. Mechanistic Insights of Pomalidomide Activity in Combination with Bortezomib and Dexamethasone in Multiple Myeloma and Immune Cells Blood. 132: 1934-1934. DOI: 10.1182/blood-2018-99-118829  0.01
2017 Henning LN, Carpenter S, Stark GV, Serbina NV. Development of protective immunity in New Zealand White rabbits challenged with Bacillus anthracis spores and treated with antibiotics and obiltoxaximab, a monoclonal antibody against protective antigen. Antimicrobial Agents and Chemotherapy. PMID 29133571 DOI: 10.1128/AAC.01590-17  0.01
2017 Nagy CF, Mondick J, Serbina N, Casey LS, Carpenter SE, French J, Guttendorf R. Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. Clinical and Translational Science. 10: 12-19. PMID 27925405 DOI: 10.1111/cts.12433  0.01
2016 Yamamoto BJ, Shadiack AM, Carpenter S, Sanford D, Henning LN, O'Connor E, Gonzales N, Mondick J, French J, Stark GV, Fisher AC, Casey LS, Serbina NV. Obiltoxaximab for Inhalational Anthrax: Efficacy Projection Across a Range of Disease Severity. Antimicrobial Agents and Chemotherapy. PMID 27431222 DOI: 10.1128/AAC.00972-16  0.01
2016 Yamamoto BJ, Shadiack AM, Carpenter S, Sanford D, Henning LN, Gonzales N, O'Connor E, Casey LS, Serbina NV. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Post-Exposure Prophylaxis in Animal Models of Inhalational Anthrax. Antimicrobial Agents and Chemotherapy. PMID 27431219 DOI: 10.1128/AAC.01102-16  0.01
1995 Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochimica Et Biophysica Acta. 1235: 289-95. PMID 7756337 DOI: 10.1016/0005-2736(95)80016-9  0.01
Hide low-probability matches.